The role of TLR4 and HO-1 in neuroinflammation after subarachnoid hemorrhage

被引:41
作者
Akamatsu, Yosuke [1 ]
Pagan, Vicente A. [2 ]
Hanafy, Khalid A. [2 ,3 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Neurosurg, Dept Surg, Boston, MA 02115 USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Neurointens Care, 3 Blackfan Circle Rm 639, Boston, MA 02115 USA
关键词
adaptive immunity; CD163; Heme-Oxygenase; innate immunity; microglia; subarachnoid hemorrhage; toll like receptor; DELAYED CEREBRAL-ISCHEMIA; EARLY BRAIN-INJURY; HIGH-DOSE METHYLPREDNISOLONE; NECROSIS-FACTOR-ALPHA; K-CA CHANNELS; CARBON-MONOXIDE; DOUBLE-BLIND; SIGNALING PATHWAYS; VASOSPASM; RECEPTOR;
D O I
10.1002/jnr.24515
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review on the mechanisms of neuroinflammation following subarachnoid hemorrhage will focus mainly on toll-like receptor 4 (TLR4), Heme Oxygenase-1 (HO-1), and the role of microglia and macrophages in this process. Vasospasm has long been the focus of research in SAH; however, clinical trials have shown that amelioration of vasospasm does not lead to an improved clinical outcome. This necessitates the need for novel avenues of research. Our work has demonstrated that microglial TLR4 and microglial HO-1, not only affects cognitive dysfunction, but also circadian dysrhythmia in a mouse model of SAH. To attempt to translate these findings, we have also begun investigating macrophages in the cerebrospinal fluid of SAH patients. The goal of this review is to provide an update on the role of TLR4, HO-1, and other signal transduction pathways in SAH-induced neuroinflammation.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 93 条
[31]   RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages [J].
Kokkola, R ;
Andersson, Å ;
Mullins, G ;
Östberg, T ;
Treutiger, CJ ;
Arnold, B ;
Nawroth, P ;
Andersson, U ;
Harris, RA ;
Harris, HE .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 61 (01) :1-9
[32]   Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer [J].
Kong, Deok-Hoon ;
Kim, Young Kwan ;
Kim, Mi Ra ;
Jang, Ji Hye ;
Lee, Sukmook .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
[33]   Identification of the haemoglobin scavenger receptor [J].
Kristiansen, M ;
Graversen, JH ;
Jacobsen, C ;
Sonne, O ;
Hoffman, HJ ;
Law, SKA ;
Moestrup, SK .
NATURE, 2001, 409 (6817) :198-201
[34]   Methemoglobin Is an Endogenous Toll-Like Receptor 4 Ligand-Relevance to Subarachnoid Hemorrhage [J].
Kwon, Min Seong ;
Woo, Seung Kyoon ;
Kurland, David B. ;
Yoon, Sung Hwan ;
Palmer, Andre F. ;
Banerjee, Uddyalok ;
Iqbal, Sana ;
Ivanova, Svetlana ;
Gerzanich, Volodymyr ;
Simard, J. Marc .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (03) :5028-5046
[35]   Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine [J].
LeBlanc, Robert H., III ;
Chen, Ruiya ;
Selim, Magdy H. ;
Hanafy, Khalid A. .
JOURNAL OF NEUROINFLAMMATION, 2016, 13
[36]   Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury [J].
Lee, Jin-Yul ;
Keep, Richard F. ;
He, Yangdong ;
Sagher, Oren ;
Hua, Ya ;
Xi, Guohua .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (11) :1793-1803
[37]   Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats [J].
Liu, Keyue ;
Mori, Shuji ;
Takahashi, Hideo K. ;
Tomono, Yasuko ;
Wake, Hidenori ;
Kanke, Toru ;
Sato, Yasuharu ;
Hiraga, Norihito ;
Adachi, Naoto ;
Yoshino, Tadashi ;
Nishibori, Masahiro .
FASEB JOURNAL, 2007, 21 (14) :3904-3916
[38]   Iron and early brain injury after subarachnoid hemorrhage [J].
Loftspring, Matthew C. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (11) :1791-1792
[39]   High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal [J].
Lotze, MT ;
Tracey, KJ .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :331-342
[40]   Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial [J].
Macdonald, R. Loch ;
Kassell, Neal F. ;
Mayer, Stephan ;
Ruefenacht, Daniel ;
Schmiedek, Peter ;
Weidauer, Stephan ;
Frey, Aline ;
Roux, Sebastien ;
Pasqualin, Alberto .
STROKE, 2008, 39 (11) :3015-3021